Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(33%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%

Trials by Status

completed133%
terminated133%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
terminated

Genetic Study of Nephrolithiasis in Gouty Diathesis

NCT00149305
unknown

Dependence Receptors and Leukemia

NCT03278145
completed

Auto-antibodies Prevalence and CD1 Role in Gaucher Disease

NCT02650219

Clinical Trials (3)

Showing 3 of 3 trials
NCT00149305

Genetic Study of Nephrolithiasis in Gouty Diathesis

Terminated
NCT03278145

Dependence Receptors and Leukemia

Unknown
NCT02650219

Auto-antibodies Prevalence and CD1 Role in Gaucher Disease

Completed

All 3 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
3